ViGeneron

News

Germany’s ViGeneron is to advance development of its next-generation ophthalmology gene therapy pipeline after a series A financing round.

News

Ultragenyx secured its first gene therapy approval, the FDA clearing GENGLYCOS as the first treatment designed to address underlying cause of GSDla.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.